Chemical Compound
Calpain inhibitor I
CAS Registry Number
110044-82-1
Primary Record
Calpain inhibitor I
- In stock
- 2,270 g
- Purity
- 99.1 %
- CAS
- 110044-82-1
Compound Identifiers & Properties
- CAS
- 110044-82-1
- PubChem CID
- 443118
- SMILES
- CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C
- Canonical SMILES
- CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O
Names & Synonyms
- Calpain inhibitor I
- Allnal
- ALLN
- Acetylleucyl-leucyl-norleucinal
- MG-101
- Ac-Leu-leu-nle-al
- 110044-82-1
- Calpain inhibitor-1
- LLnL peptide
- ALLN peptide
- N-Ac-Leu-leu-norleucinal
- AcLLNal
- LLNL
- Calp I
- N-acetylleucylleucylnorleucinal
- ALLnL
- CI-1[peptide]
- Ac-LL-Nle-aldehyde
- Ac-Leu-Leu-Nle-H
- Calpain Inhibitor I, ALLN
- CALPAIN IHIBITOR I
- Cpi(1)
- Ac-Leu-Leu-Nle-CHO
- Ac-Leu-Leu-Nle-aldehyde
- RefChem:552506
- Ac-Leu-Leu-L-norleucinal
- N-Acetyl-leucyl-leucyl-norleucinal
- UPCMLD-DP120
- AC1L9E1Z
- CHEBI:2423
- CHEMBL304784
- acetyl-leucyl-leucyl-norleucinal
- N-Acetyl-Leu-Leu-Nle-CHO
- N-acetyl-Leu-Leu-norLeu-al
- Ac-L-Leu-L-Leu-norleucinal
- BSPBio_001559
- KBioGR_000279
- KBioSS_000279
- MG-101 (ALLN)
- N-Acetyl-Leu-Leu-norleucinal
- SCHEMBL231491
- Ac-Leu-Leu-Nle-CHO; ALLN
- acetyl-leucyl-leucyl-norleucine-aldehyde
- FMYKJLXRRQTBOR-BZSNNMDCSA-N
- MFCD00065505
- Ac-Leu-Leu-Nle-H (Aldehyde)
- C20H37N3O4
- MG101
- orb1300637
- n-acetylleucyl-leucyl-norleucinal
- SCHEMBL15539031
- UPCMLD-DP120:001
- UPCMLD-DP120:002
- BCBcMAP01_000098
- GTPL13381
- IAL-3671-PI
- KBio2_000279
- KBio2_002847
- KBio2_005415
- KBio3_000557
- KBio3_000558
- DTXSID70911457
- Bio2_000279
- Bio2_000759
- HMS1361N21
- HMS1791N21
- HMS1989N21
- HMS3402N21
- acetyl-leucinyl-leucinyl-norleucinal
- EX-A3085
- ZINC3826241
- Calpain inhibitor I;Ac-LLnL-CHO;ALLN
- 2300AH
- BDBM50069792
- CID443118
- MG 101
- s7386
- AKOS024457579
- C20-H37-N3-O4
- CCG-208037
- CS-4961
- DB07558
- N-acetyl-L-leucyl-L-leucyl-L-leucinal
- Ac-Leu-Leu-[(S)-1-Formylpentyl]NH2
- IDI1_034029
- (2S)-2-[(Ac-Leu-Leu-)Amino]hexanal
- n-acetyl-l-leucinyl-l-leucinyl-l-norleucinal
- NCGC00161662-01
- NCGC00161662-02
- NCGC00161662-03
- NCGC00161662-08
- (S)-2-(Ac-L-Leu-L-Leu-)Aminohexanal
- BS-48888
- Calpain Inhibitor I, >=97.0% (TLC)
- HY-18964
- N-Acetyl-L-leucyl-L-leucyl-L-norleucinal
- (S)-2-[(Ac-L-Leu-L-Leu-)Amino]hexanal
- J675.054K
- N-Acetyl-L-leucine-L-leucine-L-norleucinal
- A2602
- Ac-L-Leu-L-Leu-[(S)-1-Formylpentyl]NH2
- ALLN - CAS 110044-82-1
- InSolution ALLN - CAS 110044-82-1
- NS00069341
- (2S)-2-[(Ac-L-Leu-L-Leu-)Amino]hexanal
- (2S)-2-[(N-Acetyl-Leu-Leu-)amino]hexanal
- (S)-2-(N-Acetyl-L-Leu-L-Leu-)aminohexanal
- (S)-2-[(N-Ac-L-Leu-L-Leu-)Amino]hexanal
- Calpain Inhibitor I, >=97% (TLC), powder
- C11306
- E78366
- A906400
- N-Acetyl-L-Leu-L-Leu-[(S)-1-formylpentyl]NH2
- (S)-2-acetamido-N-((S)-1-amino-4-methyl-1-oxopentan-2-yl)-4-methyl-N-((S)-1-oxohexan-2-yl)pentanamide
- BRD-K35923252-001-01-0
- N-{N-[N-Acetyl-(S)-leucyl]-(S)-leucyl}norleucinal
- Q27096777
- (2S)-2-acetamido-4-methyl-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]pentanamide
- (S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide
- (2S)-2-[(2S)-2-acetamido-4-methylpentanamido]-N-[(1S)-1-formylpentyl]-4-methylpentanamide
- N-Acetyl-L-leucyl-N-((1S)-1-formylpentyl)-L-leucinamide
- N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-L-leucinamide
- N-acetyl-L-leucyl-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide
- 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE
- Calpain Inhibitor I, N-Acetyl-Leu-Leu-norleucinal, synthetic
- L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]-
- N-[N-(N-Acetyl-L-leucyl)-L-leucyl]-L-norleucine, aldehyde deriv.
- Nalpha-(N-Acetyl-L-leucyl)-N-[(1S)-1-formylpentyl]-L-leucinamide
- (2S)-2-[(2S)-2-ACETAMIDO-4-METHYLPENTANAMIDO]-4-METHYL-N-[(2S)-1-OXOHEXAN-2-YL]PENTANAMIDE
- (2S)-2-((2S)-2-acetamido-4-methylpentanamido)-N-((1S)-1-formylpentyl)-4-methylpentanamide
- (2S)-2-[(1-Hydroxyethylidene)amino]-N-[(2S)-1-hydroxy-4-methyl-1-{[(2S)-1-oxohexan-2-yl]imino}pentan-2-yl]-4-methylpentanimidic acid
- (S)-N-Acetyl-L-leucyl-N-(1-formylpentyl)-L-leucinamide; ALLN; ALLnL; CI-1 (peptide); Calp I; Calpain inhibitor I; MG 101; (S)-N-Acetyl-L-leucinyl-L-leucinyl-L-norleucinal
- 2-[(1-Hydroxyethylidene)amino]-N-{1-hydroxy-4-methyl-1-[(1-oxohexan-2-yl)imino]pentan-2-yl}-4-methylpentanimidic acid
- ALLN Ac-LLnL-CHO MG-101 N-Acetyl-Leu-Leu-Norleu-al N-Acetyl-L-leucyl-L-leucyl-L-norleucinal
- ALLN, Ac-LLnL-CHO, MG-101, N-Acetyl-Leu-Leu-Norleu-al, N-Acetyl-L-leucyl-L-leucyl-L-norleucinal
- CIB